← All organizations

CinCor Pharma, Inc.

For profit

Also known as: CinCor Pharma, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Apr 6, 2022

Acquired by AstraZeneca on Jan 9, 2023

Timeline

2010s

Jun 1, 2018
CinCor Pharma, Inc.— Founded

2020s

Jan 9, 2023
AstraZeneca— Acquired By

Drugs by trial phase (2 distinct, 6 trials)

Phase 2 (1 own, 0 via acquisition)

vasopressin

Phase 1 (1 own, 0 via acquisition)

metformin

Indications

Studied for

Hypertension

Recent trials (6)

NCT05459688Lead sponsorPhase 2Apr 6, 2022
NCT05137002Lead sponsorPhase 2Nov 30, 2021
NCT04605549Lead sponsorPhase 2Jan 13, 2021
NCT05470725Lead sponsorPhase 1Jan 12, 2021
NCT05526690Lead sponsorPhase 1Oct 28, 2020
NCT04519658Lead sponsorPhase 2Jul 1, 2020

Details

Founded: Cincinnati, OH, US Jun 1, 2018
Last known activity: Apr 6, 2022